Biography and Research Information
OverviewAI-generated summary
Daniel W. Armstrong's research focuses on the separation and analysis of molecules, with a particular emphasis on chiral molecules and their role in biological systems. His work utilizes advanced chromatographic techniques, including High-Performance Liquid Chromatography (HPLC) and Gas Chromatography (GC), alongside capillary electrophoresis. A significant area of his investigation involves the application of these separation methods to identify and analyze chiral molecules as potential disease biomarkers.
His research also explores the fundamental properties of molecules, including stereoisomerism and molecular structure, and their implications in various fields. This includes studies on amino acids, specifically d-amino acids in biological contexts, and the development of novel separation materials like metal-organic frameworks and mirror-image cyclodextrins. Armstrong has also investigated specific applications such as arsenic sequestration and advancements in crystallization techniques for chiral compounds.
With a highly cited researcher designation, Armstrong has an extensive publication record of 829 papers and a citation count of over 39,000. His collaborations include work with Brendan Frett, Baku Acharya, Baha’a Jabali, and Maha Hanafi, all affiliated with the University of Arkansas for Medical Sciences. His recent publications span topics from disease biomarkers and chiral crystallization to metal-organic frameworks and d-amino acids.
Metrics
- h-index: 98
- Publications: 829
- Citations: 39,657
Selected Publications
-
Kinase inhibitor macrocycles: a perspective on limiting conformational flexibility when targeting the kinome with small molecules (2023)
-
FLT3 inhibitors for acute myeloid leukemia: successes, defeats, and emerging paradigms (2022)
Collaboration Network
Top Collaborators
- FLT3 inhibitors for acute myeloid leukemia: successes, defeats, and emerging paradigms
- Kinase inhibitor macrocycles: a perspective on limiting conformational flexibility when targeting the kinome with small molecules
- FLT3 inhibitors for acute myeloid leukemia: successes, defeats, and emerging paradigms
- Kinase inhibitor macrocycles: a perspective on limiting conformational flexibility when targeting the kinome with small molecules
- FLT3 inhibitors for acute myeloid leukemia: successes, defeats, and emerging paradigms
- Kinase inhibitor macrocycles: a perspective on limiting conformational flexibility when targeting the kinome with small molecules
- FLT3 inhibitors for acute myeloid leukemia: successes, defeats, and emerging paradigms
- Kinase inhibitor macrocycles: a perspective on limiting conformational flexibility when targeting the kinome with small molecules
- Kinase inhibitor macrocycles: a perspective on limiting conformational flexibility when targeting the kinome with small molecules
- Kinase inhibitor macrocycles: a perspective on limiting conformational flexibility when targeting the kinome with small molecules
- Kinase inhibitor macrocycles: a perspective on limiting conformational flexibility when targeting the kinome with small molecules
Similar Researchers
Based on overlapping research topics